infants breast-fed by lactating thyrotoxic mothers (53–55). Methimazole is the preferred drug, because of a risk of potential hepatotoxicity of PTU in either mother or child (56).
infants breast-fed by lactating thyrotoxic mothers (53–55). Methimazole is the preferred drug, because of a risk of potential hepatotoxicity of PTU in either mother or child (56).